Revised Statement of Deviation or Variation for the Half Year ended on 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Magenta Lifecare Ltd has submitted a revised statement of deviation or variation on fund usage to BSE. The company raised Rs. 5.98 crore through a public issue on 10 June 2024. For the half year ended 30 September 2025, the company confirms there has been no deviation or variation in the use of these funds. Out of the total amount, Rs. 424 lakhs was allocated for incremental working capital needs and Rs. 174 lakhs for general corporate purposes — both fully utilised as per the original plan. The Audit Committee and auditors have raised no comments on the fund usage. The revision only updates the deviation/v variation statement, with no other changes to the earlier Integrated Financial filing.
Neutral to positive for shareholders — the company has used IPO funds exactly as promised, with no misuse or diversion. Full utilisation in line with stated objects signals disciplined capital deployment, though the filing itself is routine compliance and is unlikely to move the stock price.